OR30-1 Safety and Efficacy of Recombinant Human Parathyroid Hormone 1-84 for the Treatment of Adults with Chronic Hypoparathyroidism: Six-Year Results of the RACE Study

RACE is an open-label study that assessed the long-term safety and efficacy of recombinant human parathyroid hormone 1-84 (rhPTH[1-84]) for the treatment of hypoparathyroidism in adults (ClinicalTrials.gov identifier NCT01297309). Patients initially received 25 or 50 µg/day of rhPTH(1-84) subcutaneo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Endocr Soc
Main Authors: Bilezikian, John, Bone, Henry, Clarke, Bart, Denham, Douglas, Lee, Hak-Myung, Levine, Michael, Mannstadt, Michael, Peacock, Munro, Rothman, Jeffrey, Sherry, Nicole, Shoback, Dolores, Vokes, Tamara, Warren, Mark, Watts, Nelson
Formato: Artigo
Idioma:Inglês
Publicado em: Endocrine Society 2019
Assuntos:
Bone and Mineral Metabolism
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6554941/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-OR30-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados